Related Experiment Video
Updated: Jul 16, 2026
12:49
Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
Published on: March 21, 2020
Red cell distribution width levels in Parkinson's disease patients.
G Kenangil1, B C Ari2, F A Kaya2
1Department of Neurology, Bahcesehir University Medical Faculty, Istanbul, Turkey. glkenangil69@gmail.com.
Acta Neurologica Belgica
|August 2, 2019
Summary
Red blood cell distribution width (RDW) levels are elevated in Parkinson's disease (PD) patients compared to healthy individuals. However, RDW did not correlate with PD severity or disease duration in this study.
Area of Science:
- Neurology
- Hematology
Background:
- Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor and non-motor symptoms.
- Oxidative stress, protein aggregation, and mitochondrial dysfunction are implicated in PD pathogenesis.
- Red blood cell (RBC) dysfunction and elevated RDW have been linked to inflammation in various diseases.
Purpose of the Study:
- To investigate Red blood cell distribution width (RDW) levels in Parkinson's disease patients.
- To explore the relationship between RDW values and the clinical severity of PD.
Main Methods:
- A case-control study involving 94 PD patients and 97 healthy controls.
- Assessment of PD severity using the United Parkinson's Disease Rating Scale (UPDRS) and Hoehn and Yahr (H&Y) staging.
- Comparison of RDW levels between PD patients and controls, and correlation analysis with clinical parameters.
Main Results:
- RDW levels were significantly higher in PD patients compared to healthy controls.
- No significant correlation was found between RDW levels and PD severity (UPDRS or H&Y scores).
- RDW showed no association with disease duration or other blood parameters.
Conclusions:
- Elevated RDW in Parkinson's disease patients suggests a potential link to underlying pathological processes.
- RDW levels do not appear to be a reliable marker for disease severity or duration in PD.
- Further large-scale studies are warranted to elucidate the role of RDW as an inflammatory marker in PD.
Related Concept Videos
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...